Alpine Immune Sciences Earnings Perspective: Return On Capital Employed
Alpine Immune Sciences (NASDAQ:ALPN) brought in sales totaling $4.53 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 12.4%, resulting in a loss of $15.17 million.
Why Alpine Immune’s Shares Are Falling Today
The FDA has placed a partial clinical hold on Alpine Immune Sciences Inc’s (NASDAQ:ALPN) NEON-2 trial evaluating davoceticept (ALPN-202) in combination with…
50 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87.
Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday.
Alpine Immune Sciences Q3 EPS $(0.55) Down From $(0.28) YoY, Sales $8.52M Up From $1.91M YoY
Alpine Immune Sciences (NASDAQ:ALPN) reported quarterly losses of $(0.55) per share. This is a 96.43 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $8.52 million
Notable Insider Buys Of The Past Week Include Designer Brands, MacroGenics And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.
The week's most notable insider buys were at two biotechs, a chemicals company and a shoemaker.
Some insiders were making return trips to the buy window.
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.